CLINICAL_TRIALS
trial_result
· 2017-05-11
Clinical Trial Update: Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access [Phase 3]
Summary
A Phase 3 roll-over/extended-access protocol provides atazanavir and/or Truvada for people with HIV, with results posted in May 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: HIV | Phase 3 | Status: COMPLETED | Results posted: 2017-05-11